Published in Med Care on August 01, 2002
Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. J Natl Cancer Inst (2009) 4.87
Extent of surgery affects survival for papillary thyroid cancer. Ann Surg (2007) 4.73
Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst (2008) 4.53
Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur Urol (2011) 2.69
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34
Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer (2008) 2.23
Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration. Am J Ophthalmol (2011) 2.07
Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg (2009) 2.02
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med (2004) 1.97
Reduction in physician reimbursement and use of hormone therapy in prostate cancer. J Natl Cancer Inst (2010) 1.91
Disparities in breast cancer treatment and survival for women with disabilities. Ann Intern Med (2006) 1.78
Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol Oncol (2011) 1.77
Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol (2013) 1.74
Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer? Eur Urol (2012) 1.64
Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy. J Am Coll Surg (2011) 1.64
Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer (2007) 1.57
Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology (2012) 1.54
Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical management. Urology (2013) 1.51
Effects of socioeconomic status on colon cancer treatment accessibility and survival in Toronto, Ontario, and San Francisco, California, 1996-2006. Am J Public Health (2010) 1.51
Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford) (2011) 1.44
External validation of a claims-based algorithm for classifying kidney-cancer surgeries. BMC Health Serv Res (2009) 1.40
Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes? J Am Coll Surg (2014) 1.38
Racial segregation and disparities in breast cancer care and mortality. Cancer (2008) 1.28
Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study. BMC Health Serv Res (2011) 1.19
Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery (2011) 1.17
Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database. J Hematol Oncol (2009) 1.16
Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: the Neighborhood and Breast Cancer Study. Cancer Epidemiol Biomarkers Prev (2014) 1.09
Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer (2006) 1.08
Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf (2013) 1.05
Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer (2007) 1.05
Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis. Ann Surg (2013) 1.04
Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults. Cancer (2011) 1.04
Osteosarcoma: improvement in survival limited to high-grade patients only. J Cancer Res Clin Oncol (2010) 1.03
Early stage breast cancer treatments for younger Medicare beneficiaries with different disabilities. Health Serv Res (2008) 1.02
Mediation of the effects of living in extremely poor neighborhoods by health insurance: breast cancer care and survival in California, 1996 to 2011. Int J Equity Health (2013) 1.02
A method to predict breast cancer stage using Medicare claims. Epidemiol Perspect Innov (2010) 1.01
Effects of being uninsured or underinsured and living in extremely poor neighborhoods on colon cancer care and survival in California: historical cohort analysis, 1996-2011. BMC Public Health (2012) 1.00
Validation of colorectal cancer surgery data from administrative data sources. BMC Med Res Methodol (2012) 0.99
Diagnostic imaging and biopsy use among elderly medicare beneficiaries with hepatocellular carcinoma. J Oncol Pract (2011) 0.98
Racial disparities in the treatment of advanced epithelial ovarian cancer. Obstet Gynecol (2013) 0.97
Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants. Med Care (2008) 0.96
Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer. Gynecol Oncol (2011) 0.95
Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data. Cancer (2009) 0.95
Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care? Health Serv Res (2013) 0.95
Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer (2011) 0.92
Sensitivity of Medicare claims data for measuring use of standard multiagent chemotherapy regimens. Med Care (2014) 0.92
Outcomes following local therapy for early-stage breast cancer in non-trial populations. Breast Cancer Res Treat (2010) 0.92
Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival. Int J Radiat Oncol Biol Phys (2009) 0.91
Postoperative radiotherapy for elderly patients with stage III lung cancer. Cancer (2012) 0.91
Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography. Med Care (2016) 0.91
Quality of life changes during the pre- to postdiagnosis period and treatment-related recovery time in older women with breast cancer. Cancer (2014) 0.91
The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence. Ann Surg (2012) 0.90
Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients. Med Care (2016) 0.90
Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care (2011) 0.90
Survival implications associated with variation in mastectomy rates for early-staged breast cancer. Int J Surg Oncol (2012) 0.89
The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma. J Natl Cancer Inst (2015) 0.89
Managed care and cancer outcomes for Medicare beneficiaries with disabilities. Am J Manag Care (2008) 0.88
Long-term central venous catheter use and risk of infection in older adults with cancer. J Clin Oncol (2014) 0.88
Trends in outpatient breast cancer surgery among Medicare fee-for-service patients in the United States from 1993 to 2002. Chin J Cancer (2011) 0.87
Treatment and Mortality in Men with Localized Prostate Cancer: A Population-Based Study in California. Open Prost Cancer J (2013) 0.87
Radiotherapy Planning Complexity and Survival after Treatment of Advanced Stage Lung Cancer in the Elderly. Cancer (2009) 0.87
Patterns of care in older patients with squamous cell carcinoma of the head and neck: a surveillance, epidemiology, and end results-medicare analysis. J Geriatr Oncol (2013) 0.87
Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims Database. J Gastric Cancer (2015) 0.86
Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer. J Community Health (2015) 0.86
Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model. Urol Oncol (2014) 0.86
Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly. Obstet Gynecol (2011) 0.85
The association of race with timeliness of care and survival among Veterans Affairs health care system patients with late-stage non-small cell lung cancer. Cancer Manag Res (2013) 0.84
Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database. Clin Orthop Relat Res (2009) 0.83
Postoperative 30-day mortality in patients undergoing surgery for colorectal cancer: development of a prognostic model using administrative claims data. Cancer Causes Control (2014) 0.83
Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage I lung cancer in the elderly. Eur J Surg Oncol (2012) 0.82
Comparative assessment of the safety and effectiveness of radiofrequency ablation among elderly medicare beneficiaries with hepatocellular carcinoma. Ann Surg Oncol (2011) 0.82
Treatment and outcomes of gastric cancer among United States-born and foreign-born Asians and Pacific Islanders. Cancer (2009) 0.82
Severe genitourinary toxicity following radiation therapy for prostate cancer--how long does it last? J Urol (2012) 0.81
Managed care market share and primary treatment for cancer. Health Serv Res (2006) 0.81
Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Obstet Gynecol (2015) 0.81
Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol (2016) 0.80
Balancing cardiovascular (CV) and cancer death among patients with small renal masses: modification by CV risk. BJU Int (2014) 0.80
Intended versus inferred care after PET performed for initial staging in the National Oncologic PET Registry. J Nucl Med (2013) 0.79
Outcomes after endoscopic versus surgical therapy for early esophageal cancers in an older population. Gastrointest Endosc (2016) 0.79
Intended versus inferred management after PET for cancer restaging: analysis of Medicare claims linked to a coverage with evidence development registry. Med Care (2013) 0.79
Radiotherapy and chemotherapy for elderly patients with stage I-II unresected lung cancer. Eur Respir J (2012) 0.79
Classification and sequential pattern analysis for improving managerial efficiency and providing better medical service in public healthcare centers. Healthc Inform Res (2010) 0.79
Patient, hospital, and geographic disparities associated with comanagement during hospitalization for colorectal cancer surgery. J Hosp Med (2014) 0.78
Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer. J Thorac Oncol (2015) 0.78
An algorithm to identify the development of lymphedema after breast cancer treatment. J Cancer Surviv (2014) 0.78
Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse. Prostate Cancer Prostatic Dis (2015) 0.77
Provider Differences in Use of Implanted Ports in Older Adults With Cancer. Med Care (2015) 0.76
Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community. Cancer (2014) 0.75
ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS. J Appl Econ (Chichester Engl) (2015) 0.75
Colon Cancer Staging in Vulnerable Older Adults: Adherence to National Guidelines and Impact on Survival. Ann Hematol Oncol (2015) 0.75
Managed care and the dissemination of robotic prostatectomy. Surg Innov (2014) 0.75
Trends in malignant intraductal papillary mucinous neoplasm in US adults from 1990 to 2010: a SEER database analysis. Gastroenterol Rep (Oxf) (2016) 0.75
The accuracy and completeness for receipt of colorectal cancer care using Veterans Health Administration administrative data. BMC Health Serv Res (2016) 0.75
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst (2008) 7.85
Variations in morbidity after radical prostatectomy. N Engl J Med (2002) 7.26
Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev (2006) 6.67
Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer (2004) 6.41
Utility of the SEER-Medicare data to identify chemotherapy use. Med Care (2002) 5.07
Assessing comorbidity using claims data: an overview. Med Care (2002) 4.94
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol (2007) 4.81
Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med (2004) 4.49
Studying radiation therapy using SEER-Medicare-linked data. Med Care (2002) 4.13
Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2008) 3.64
Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care (2002) 3.57
Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care (2002) 3.36
Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med (2009) 3.34
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst (2006) 3.19
Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med (2011) 3.11
Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients. Med Care (2006) 3.08
A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01
Patient time costs associated with cancer care. J Natl Cancer Inst (2007) 2.90
Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol (2012) 2.77
Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? J Clin Oncol (2008) 2.62
Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med (2003) 2.56
In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care (2006) 2.53
Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol (2013) 2.32
Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 2.31
Identifying cancer relapse using SEER-Medicare data. Med Care (2002) 2.28
Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev (2008) 2.20
Impact of a scientific presentation on community treatment patterns for primary breast cancer. J Natl Cancer Inst (2006) 2.12
Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst (2005) 2.08
Measuring complications of cancer treatment using the SEER-Medicare data. Med Care (2002) 2.05
Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev (2007) 2.02
Health care provider surveys in the United States, 2000-2010: a review. Eval Health Prof (2013) 2.02
Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst (2006) 2.01
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer (2009) 2.01
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med (2004) 1.97
Limits of observational data in determining outcomes from cancer therapy. Cancer (2008) 1.97
Estimating patient time costs associated with colorectal cancer care. Med Care (2005) 1.94
Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev (2003) 1.83
Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care (2009) 1.76
Trends in end-of-life ICU use among older adults with advanced lung cancer. Chest (2007) 1.76
Colorectal cancer screening barriers and facilitators in older persons. Prev Med (2009) 1.73
Cancer screening test use - United States, 2013. MMWR Morb Mortal Wkly Rep (2015) 1.72
Continuity of care and intensive care unit use at the end of life. Arch Intern Med (2009) 1.70
Trends in colorectal cancer test use in the medicare population, 1998-2005. Am J Prev Med (2009) 1.68
Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol (2002) 1.63
Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care (2009) 1.62
Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med (2013) 1.62
Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol (2011) 1.59
Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev (2008) 1.59
Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors. J Cancer Surviv (2007) 1.56
Overview of the SEER--Medicare Health Outcomes Survey linked dataset. Health Care Financ Rev (2008) 1.55
Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol (2007) 1.54
Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J Clin Oncol (2002) 1.52
Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med (2010) 1.47
A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer (2004) 1.45
Are physicians' recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med (2010) 1.44
Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med (2010) 1.42
External validation of a claims-based algorithm for classifying kidney-cancer surgeries. BMC Health Serv Res (2009) 1.40
Measuring breast, colorectal, and prostate cancer screening with medicare claims data. Med Care (2002) 1.37
Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources. Med Care (2002) 1.36
Comanagement of hospitalized surgical patients by medicine physicians in the United States. Arch Intern Med (2010) 1.36
Identifying specific chemotherapeutic agents in Medicare data: a validation study. Med Care (2013) 1.36
Physicians' colorectal cancer screening discussion and recommendation patterns. Cancer Epidemiol Biomarkers Prev (2011) 1.35
Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. Med Care (2004) 1.31
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med (2003) 1.30
Screening colonoscopy in the US: attitudes and practices of primary care physicians. J Gen Intern Med (2012) 1.30
Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol (2013) 1.29
Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Health (Larchmt) (2012) 1.28
Systems strategies to support cancer screening in U.S. primary care practice. Cancer Epidemiol Biomarkers Prev (2011) 1.28
Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res (2003) 1.27
Late gastrointestinal toxicity after radiation for prostate cancer. Cancer (2006) 1.25
Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care (2014) 1.24
Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service. Cancer Epidemiol Biomarkers Prev (2008) 1.24
Can cancer registry data be used to study cancer treatment? Med Care (2003) 1.23
Are there gender differences in colorectal cancer test use prevalence and correlates? Cancer Epidemiol Biomarkers Prev (2006) 1.22
Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 1.22
Methodological issues in the use of administrative claims data to study surveillance after cancer treatment. Med Care (2002) 1.21
Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol (2011) 1.20
Racial differences in colorectal cancer test use by Medicare consumers. Am J Prev Med (2006) 1.16
Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med (2010) 1.16
The CTSA as an exemplar framework for developing multidisciplinary translational teams. Clin Transl Sci (2012) 1.14
Unveiling SEER-CAHPS®: a new data resource for quality of care research. J Gen Intern Med (2015) 1.13
Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States. Cancer (2011) 1.12
National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med (2013) 1.11
Multiple clinical practice guidelines for breast and cervical cancer screening: perceptions of US primary care physicians. Med Care (2011) 1.10
Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients. J Clin Epidemiol (2013) 1.10
Breast and colorectal cancer screening: U.S. primary care physicians' reports of barriers. Am J Prev Med (2012) 1.10
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10
The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer (2007) 1.08
Association of polypectomy techniques, endoscopist volume, and facility type with colonoscopy complications. Gastrointest Endosc (2013) 1.07